Company Analysis UpHealth, Inc.
1. Summary
Advantages
- Price (0.35 $) is less than fair price (0.7259 $)
Disadvantages
- Dividends (0%) are below the sector average (1.24%).
- The stock's return over the last year (-64.29%) is lower than the sector average (-26.12%).
- Current debt level 46.35% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-105.25%) is lower than the sector average (ROE=-80.94%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| UpHealth, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 2.3% | 0.6% |
| 90 days | 0% | -36.1% | 9.2% |
| 1 year | -64.3% | -26.1% | 33.2% |
UPH vs Sector: UpHealth, Inc. has significantly underperformed the "Healthcare" sector by -38.16% over the past year.
UPH vs Market: UpHealth, Inc. has significantly underperformed the market by -97.46% over the past year.
Stable price: UPH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: UPH with weekly volatility of -1.24% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.35 $) is lower than the fair price (0.7259 $).
Price significantly below the fair price: The current price (0.35 $) is 107.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.99).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.41).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.2562) is lower than that of the sector as a whole (9.41).
P/BV vs Market: The company's P/BV (0.2562) is lower than that of the market as a whole (22.54).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.1712) is lower than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (0.1712) is lower than that of the market as a whole (15.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-65.4) is lower than that of the sector as a whole (17.44).
EV/Ebitda vs Market: The company's EV/Ebitda (-65.4) is lower than that of the market as a whole (22.02).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -15125.72% over the last 5 years.
Accelerating profitability: The return for the last year (-58.08%) exceeds the average return for 5 years (-15125.72%).
Profitability vs Sector: The return for the last year (-58.08%) is lower than the return for the sector (-14.25%).
5.4. ROE
ROE vs Sector: The company's ROE (-105.25%) is lower than that of the sector as a whole (-80.94%).
ROE vs Market: The company's ROE (-105.25%) is lower than that of the market as a whole (16.9%).
5.5. ROA
ROA vs Sector: The company's ROA (-49.04%) is lower than that of the sector as a whole (6.66%).
ROA vs Market: The company's ROA (-49.04%) is lower than that of the market as a whole (6.57%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-77.61%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (-77.61%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.24%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
